Initial Antibiotic Selection and Patient Outcomes: Observations from the National Pneumonia Project
Open Access
- 1 December 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (S3) , S193-S201
- https://doi.org/10.1086/591404
Abstract
Background. Guidelines for empirical treatment of hospitalized patients with pneumonia provide specific recommendations for antibiotic selection that are primarily based on findings from observational studies. Methods. We conducted a retrospective study of 27,330 community-dwelling, immunocompetent Medicare patients (age, >65 years) with pneumonia who were hospitalized in 1998–1999 and 2000–2001. Associations between initial antimicrobial regimens and risk-adjusted mortality were assessed, accounting for differences in patient characteristics, comorbidities, illness severity, geographic location, and processes of care. Treatment with non-pseudomonal third-generation cephalosporin monotherapy constituted the reference group for comparisons. Results. For patients not in the intensive care unit, initial treatment with fluoroquinolone monotherapy was associated with reduced in-hospital mortality, 14-day mortality, and 30-day mortality rates (adjusted odds ratio [AOR] for 30-day mortality, 0.7; 95% confidence interval [CI], 0.6–0.9; P=.001). The combination of a cephalosporin plus a macrolide was associated with reduced 14-day and 30-day mortality rates (AOR for 30-day mortality, 0.7; 95% CI, 0.6–0.9; P<.001). For intensive care unit patients, the combination of a cephalosporin and a macrolide was associated with reduced in-hospital mortality (AOR, 0.6; 95% CI, 0.3–0.9; P=.018). Conclusions. Initial antimicrobial treatment with the combination of a second- or third-generation cephalosporin and a macrolide or initial treatment with a fluoroquinolone was associated with a reduced 30-day mortality rate, compared with treatment with third-generation cephalosporin monotherapy, among non–intensive care unit patients. Although our results are consistent with other observational studies, controversy continues to exist about the use of nonexperimental cohort studies to demonstrate associations between processes of care, such as antibiotic selection, and patient outcomes.Keywords
This publication has 24 references indexed in Scilit:
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2007
- Impact of Guideline-Concordant Empiric Antibiotic Therapy in Community-Acquired PneumoniaThe American Journal of Medicine, 2006
- Improved Clinical Outcomes With Utilization of a Community-Acquired Pneumonia GuidelineChest, 2006
- Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumoniaThe American Journal of Medicine, 2004
- Inpatient Care of Community‐Acquired Pneumonia: The Effect of Antimicrobial Guidelines on Clinical Outcomes and Drug Costs in Canadian Teaching HospitalsCanadian Respiratory Journal, 2004
- Impact of Initial Antibiotic Choice on Clinical Outcomes in Community-Acquired PneumoniaChest, 2003
- Rapid Antibiotic Delivery and Appropriate Antibiotic Selection Reduce Length of Hospital Stay of Patients With Community-Acquired PneumoniaArchives of internal medicine (1960), 2002
- Empiric Antibiotic Therapy and Mortality Among Medicare Pneumonia Inpatients in 10 Western StatesChest, 2001
- Antimicrobial Selection for Hospitalized Patients with Presumed Community-Acquired Pneumonia: A Survey of Nonteaching US Community HospitalsAnnals of Pharmacotherapy, 2000
- Associations Between Initial Antimicrobial Therapy and Medical Outcomes for Hospitalized Elderly Patients With PneumoniaArchives of internal medicine (1960), 1999